glp-1 and vertigo from Injections Electrolytes for GLP-1 Dizziness: Why

Why NAION Is Being Investigated in GLP-1 Lawsuits Medical researchers and attorneys are examining whether GLP-1 receptor agonist drugs including Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound may increase the risk of NAION in certain patients

They joined prior risk factors such as hearing loss, hypertension, smoking, obesity, depression, physical inactivity, diabetes, excessive alcohol use, traumatic brain injury, air pollution, social isolation, and lower educational attainment

Often, skipping one week or lowering the dose is enough to resolve the issue

With the obesity epidemic and the rising prevalence of cardiometabolic diseases, understanding adipose tissue function and distribution becomes critical

Think long-term: View your GLP-1 medication as an aid, not the main component